Literature DB >> 22528765

Therapeutic options for low bone mineral density in HIV-infected subjects.

Aoife G Cotter1, Patrick W G Mallon.   

Abstract

With the advent of effective antiretroviral therapy (ART), the recognition and management of long-term complications of HIV infection and ART are increasingly important for HIV physicians. Low bone mineral density (BMD) is more common in those with HIV infection and this review will outline therapeutic options for the management of low bone mineral density relevant to HIV-infected populations.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22528765     DOI： 10.1007/s11904-012-0117-9

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN： 1548-3568            Impact factor:   5.071


  102 in total

1.  Efficacy of strontium ranelate on bone mineral density in men with osteoporosis.

Authors:  Johann D Ringe; Alfred Dorst; Parvis Farahmand
Journal:  Arzneimittelforschung       Date:  2010

2.  Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens.

Authors:  Todd T Brown; Allison C Ross; Norma Storer; Danielle Labbato; Grace A McComsey
Journal:  Antivir Ther       Date:  2011

3.  Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.

Authors:  Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Yungtai Lo; Robert S Klein
Journal:  AIDS       Date:  2007-03-12       Impact factor: 4.177

4.  Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).

Authors:  Sylvie Rozenberg; Emillie Lanoy; Michelle Bentata; Jean-Paul Viard; Marc Antoine Valantin; Pascale Missy; Iuliana Darasteanu; Christian Roux; Sami Kolta; Dominique Costagliola
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-23       Impact factor: 2.205

5.  Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis.

Authors:  Joel S Finkelstein; Jason J Wyland; Hang Lee; Robert M Neer
Journal:  J Clin Endocrinol Metab       Date:  2010-02-17       Impact factor: 5.958

6.  The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1-34)].

Authors:  Etah S Kurland; Samantha L Heller; Beverly Diamond; Donald J McMahon; Felicia Cosman; John P Bilezikian
Journal:  Osteoporos Int       Date:  2004-06-03       Impact factor: 4.507

7.  Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety.

Authors:  John L Vahle; Masahiko Sato; Gerald G Long; Jamie K Young; Paul C Francis; Jeffery A Engelhardt; Michael S Westmore; Yanfei Linda; James B Nold
Journal:  Toxicol Pathol       Date:  2002 May-Jun       Impact factor: 1.902

8.  HIV infection and bone mineral density in middle-aged women.

Authors:  Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Nanette Santoro; Ellie E Schoenbaum
Journal:  Clin Infect Dis       Date:  2006-02-24       Impact factor: 9.079

9.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24

Review 10.  Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.

Authors:  Mark J Bolland; Alison Avenell; John A Baron; Andrew Grey; Graeme S MacLennan; Greg D Gamble; Ian R Reid
Journal:  BMJ       Date:  2010-07-29
View more
  5 in total

1.  Relationships Between Physical Activity and Bone Density in People Living with HIV: Results from the SATURN-HIV Study.

Authors:  Joseph D Perazzo; Allison R Webel; S M Khurshid Alam; Abdus Sattar; Grace A McComsey
Journal:  J Assoc Nurses AIDS Care       Date:  2018-03-28       Impact factor: 1.354

Review 2.  HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.

Authors:  Micol S Rothman; Mary T Bessesen
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

Review 3.  People Living With HIV: Implications for Rehabilitation Nurses.

Authors:  Joseph D Perazzo; Allison R Webel; Ellen McGough; Joachim Voss
Journal:  Rehabil Nurs       Date:  2018 May/Jun       Impact factor: 1.625

Review 4.  Adverse bone health among children and adolescents growing up with HIV.

Authors:  Tavitiya Sudjaritruk; Thanyawee Puthanakit
Journal:  J Virus Erad       Date:  2015-07-01

Review 5.  Ageing with HIV.

Authors:  Padraig McGettrick; Elena Alvarez Barco; Patrick W G Mallon
Journal:  Healthcare (Basel)       Date:  2018-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.